
To find the maximum tolerated dose zzso of zzso in combination with zzso in patients with advanced solid zzso 

This was a Phase I study using cohort dose escalation of zzso zzso orally twice daily in combination with zzso 12 zzso given on Day 1 of each zzso zzso 

zzso dose was escalated to 1,000 zzso zzso zzso One patient experienced a zzso toxicity zzso Three patients discontinued the study due to adverse events zzso Two patients zzso had a partial response, and ten patients zzso had stable disease as best zzso 

The combination of zzso and zzso was well zzso zzso escalation was stopped because of zzso in a concurrent Phase I zzso The response rate seen in patients with prostate cancer was comparable to response rates seen in trials of zzso and prednisone alone, and further studies of the combination of zzso and zzso were not zzso 

